COR Cencora
Updated
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cencora (COR) is a industrials company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $64.3 billion. Shares last traded at $337.13, 10.7% below their 52-week high. Over the past year the stock is up 14.2%. COR trades at a price-to-earnings ratio of 24.51, above the Wholesale-Drugs, Proprietaries & Druggists' Sundries median of 23.95. Net profit margin is 0.8%, above the peer median of 0.7%. Revenue grew 9.3% year over year. The shares yield 0.7% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
COR Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-09-30 | $437M | $2.24 | 28% |
| 2024-09-30 | $416M | $2.08 | 28% |
| 2023-09-30 | $399M | $1.95 | 23% |
| 2022-09-30 | $392M | $1.85 | 23% |
| 2021-09-30 | $367M | $1.76 | 24% |
| 2020-09-30 | $344M | $1.68 | — |
| 2019-09-30 | $339M | $1.60 | 40% |
| 2018-09-30 | $333M | $1.51 | 20% |
| 2017-09-30 | $320M | $1.45 | 88% |
| 2016-09-30 | $288M | $1.28 | 20% |
| 2015-09-30 | $254M | $1.17 | — |
| 2014-09-30 | $214M | $0.91 | 78% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q3 2026 | $15.21 | 2026-08-05 |
| Q2 2026 | $11.27 | 2026-05-06 |
| Q1 2026 | $2.87 | 2026-02-04 |
| FY 2025 | $7.96 | 2025-11-25 |
| Q3 2026 | $9.70 | 2026-08-05 |
| Q2 2026 | $6.18 | 2026-05-06 |
Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
COR vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Updated
| MCK | McKesson Corporation | $107.4B | 23.39 | 0.26 | 1.1% | -0.40% |
| COR | Cencora | $64.3B | 24.51 | 0.19 | 0.8% | +0.23% |
| CAH | Cardinal Health | $57.8B | 34.78 | 0.24 | 0.7% | +1.24% |
| HLF | Herbalife Ltd. | $1.3B | 7.76 | 0.25 | 3.2% | -0.08% |
| NUS | NU SKIN ENTERPRISES, INC. | $228M | -1.05 | 0.17 | -15.7% | -2.90% |
| COSM | Cosmos Health Inc. | $27M | -1.10 | 0.37 | -33.1% | +18.78% |
| HWH | HWH International Inc. | $15M | -5.54 | — | — | +2.98% |
| MEDS | DataMeds AI, Inc. | $3M | -0.03 | — | — | -4.49% |
| HKPD | Cellyan Biotechnology Co., Ltd | — | — | — | — | -7.89% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.